Replies to post #100988 on Biotech Values

[zipjet]

it’s actually closer to 7.5 years since Teva submitted its Lovenox ANDA. Teva notified SNY (then d/b/a Aventis Pharmaceuticals) of its Paragraph-IV challenge in Jun 2003, following FDA acceptance of Teva’s ANDA for review.

It sure took them a long time to act arbitrarily and capriciously.

;-)

ij